The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience

[1]  H. Buchholz,et al.  Primary Staging of Prostate Cancer Patients with [18F]PSMA-1007 PET/CT Compared with [68Ga]Ga-PSMA-11 PET/CT , 2022, Journal of clinical medicine.

[2]  Y. Gan,et al.  Optimization of prostate cancer patient lymph node staging via the integration of neutrophil–lymphocyte ratios, platelet–lymphocyte ratios, and 68Ga‐PSMA‐PET‐derived SUVmax values , 2022, The Prostate.

[3]  J. Zang,et al.  [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  W. Cai,et al.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  E. Demirci,et al.  Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET , 2022, Biomedicines.

[6]  J. Czernin,et al.  Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study , 2021, The Journal of Nuclear Medicine.

[7]  L. Umutlu,et al.  Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis , 2021, The Journal of Nuclear Medicine.

[8]  J. Debus,et al.  Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  U. Haberkorn,et al.  Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review , 2021, EJNMMI Research.

[10]  J. Czernin,et al.  Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study , 2020, The Journal of Nuclear Medicine.

[11]  Hua Wu,et al.  Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. , 2020, Radiology.

[12]  N. Valli,et al.  Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  U. Haberkorn,et al.  The Latest Developments in Imaging of Fibroblast Activation Protein , 2020, The Journal of Nuclear Medicine.

[14]  Haitao Zhao,et al.  Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Hua Wu,et al.  Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Hua Wu,et al.  Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  Thomas Lindner,et al.  Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy , 2020, The Journal of Nuclear Medicine.

[18]  J. Debus,et al.  The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience , 2020, The Journal of Nuclear Medicine.

[19]  F. Izzo,et al.  Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection , 2019, BMC gastroenterology.

[20]  H. Kauczor,et al.  FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Masahide Takahashi,et al.  Cancer-associated fibroblasts in gastrointestinal cancer , 2019, Nature Reviews Gastroenterology & Hepatology.

[22]  E. Song,et al.  Turning foes to friends: targeting cancer-associated fibroblasts , 2018, Nature Reviews Drug Discovery.

[23]  D. Jäger,et al.  A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts , 2018, The Journal of Nuclear Medicine.

[24]  Frederik L. Giesel,et al.  68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.

[25]  S. Kramer,et al.  Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation , 2018, European Radiology.

[26]  E. Puré,et al.  Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. , 2017, JCI insight.

[27]  M. Schwartz,et al.  Force regulated conformational change of integrin αVβ3. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[28]  Fan Wang,et al.  Integrin Imaging with 99mTc-3PRGD2 SPECT/CT Shows High Specificity in the Diagnosis of Lymph Node Metastasis from Non-Small Cell Lung Cancer. , 2016, Radiology.

[29]  E. Puré,et al.  Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. , 2015, Cancer research.

[30]  F. Izzo,et al.  The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA “uptake” on the hepatobiliary phase of MR imaging , 2015, Abdominal Imaging.

[31]  J. Bing,et al.  Pharmacokinetics and radiation dosimetry of ~(99m)Tc-3PRGD_2 in healthy individuals:A pilot study , 2013 .

[32]  Wei Wei,et al.  Metastatic patterns in adenocarcinoma , 2006, Cancer.

[33]  D. Rubello,et al.  Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  S. Welch,et al.  Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).